Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Immunoconjugates × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Breast 3 Tumor-Agnostic 2 Lymphoid 2 Sarcoma 1 Plasma cell 1 Genitourinary 1

Conditions

Interventions

Radiotherapy 215 Cyclophosphamide 211 Doxorubicin 207 Temozolomide 181 Ifosfamide 121 Filgrastim 111 Etoposide 101 Imatinib Mesylate 98 Vincristine 92 Gemcitabine 88 Bevacizumab 82 Irinotecan 79 Magnetic Resonance Spectroscopy 77 pembrolizumab 75 Radiation 66 Carboplatin 65 pazopanib 60 Methotrexate 59 Cisplatin 58 fludarabine phosphate 57 Nivolumab 57 Peripheral Blood Stem Cell Transplantation 56 Specimen Handling 52 Docetaxel 50 Busulfan 48 Trabectedin 47 Biopsy 47 Melphalan 46 Surgical Procedures, Operative 44 Paclitaxel 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06797999 2026-01-28

ADCElerate1

Adcendo ApS

Phase 1/2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡